NCT06158750View on ClinicalTrials.gov

To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions
Intracranial Aneurysm
Interventions
DEVICE

p64/p48 MW HPC Flow Modulation Device

Endovascular intervention with p64/p48 MW HPC Flow Modulation Device was performed in patients diagnosed with intracranial aneurysms

Trial Locations (1)

Unknown

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

Sponsors

Collaborators (1)

Phenox GmbH
All Listed Sponsors
collaborator

Phenox GmbH

INDUSTRY

collaborator

Beijing Wallaby Medical Technologies Co.,Inc.

UNKNOWN

lead

Shanghai Wallaby Medical Technologies Co.,Inc.

INDUSTRY

NCT06158750 - To Evaluate the Safety and Effectiveness of Flow Modulation Device for Intracranial Aneurysms | Biotech Hunter | Biotech Hunter